DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL.
Division of Nephrology and Hypertension, Leonard M. Miller School of Medicine, University of Miami, Miami, FL.
Am J Kidney Dis. 2019 Jul;74(1):73-81. doi: 10.1053/j.ajkd.2018.12.035. Epub 2019 Feb 27.
RATIONALE & OBJECTIVE: Improving arteriovenous fistula (AVF) outcomes requires better understanding of the biology underlying maturation or failure. Our current knowledge of maturation relies on extrapolation from other vascular pathologies, which does not incorporate unique aspects of AVF remodeling. This study compares the RNA expression of pre-access (native) veins and AVFs with distinct maturation outcomes.
Case-control study.
SETTING & PARTICIPANTS: 64 patients undergoing 2-stage AVF surgeries at a single center. 19 native veins and 19 AVF samples were analyzed using RNA sequencing (RNA-seq). 58 native veins were studied using real-time polymerase chain reaction; 45, using immunohistochemistry; and 19, using Western blot analysis.
RNA expression in native veins and AVFs.
Anatomic nonmaturation, defined as an AVF that never achieved an internal diameter ≥ 6mm.
Pre-access native veins and AVF samples were obtained from patients undergoing 2-stage AVF creation. Veins that subsequently matured or failed after access creation were analyzed using RNA-seq to search for genes associated with maturation failure. Genes associated with nonmaturation were confirmed using real-time polymerase chain reaction, immunohistochemistry, and Western blot analysis. In addition, the association between pre-access gene expression and postoperative morphology was evaluated. RNA-seq was also performed on AVFs to search for transcriptional differences between AVFs that matured and those that failed at the time of transposition.
Pro-inflammatory genes (CSF3R, FPR1, S100A8, S100A9, and VNN2) were upregulated in pre-access veins that failed (false discovery rate < 0.05), and their expression colocalized to smooth muscle cells. Expression of S100A8 and S100A9 correlated with postoperative intimal hyperplasia and the product of medial fibrosis and intimal hyperplasia (r=0.32-0.38; P < 0.05). AVFs that matured or failed were transcriptionally similar at the time of transposition.
Small sample size, analysis of only upper-arm veins and transposed fistulas.
Increased expression of proinflammatory genes in pre-access veins appears to be associated with greater risk for AVF nonmaturation.
提高动静脉瘘(AVF)的效果需要更好地了解成熟或失败的生物学基础。我们目前对成熟的认识依赖于从其他血管病变推断而来,而这些推断并未纳入 AVF 重塑的独特方面。本研究比较了具有不同成熟结果的术前(天然)静脉和 AVF 的 RNA 表达。
病例对照研究。
在单一中心接受两阶段 AVF 手术的 64 名患者。使用 RNA 测序(RNA-seq)分析 19 个天然静脉和 19 个 AVF 样本。使用实时聚合酶链反应研究 58 个天然静脉;45 个使用免疫组织化学研究;19 个使用 Western blot 分析。
天然静脉和 AVF 中的 RNA 表达。
解剖学不成熟,定义为 AVF 从未达到≥6mm 的内部直径。
从接受两阶段 AVF 形成的患者中获得术前天然静脉和 AVF 样本。在创建血管通路后成熟或失败的静脉使用 RNA-seq 进行分析,以寻找与成熟失败相关的基因。使用实时聚合酶链反应、免疫组织化学和 Western blot 分析证实与非成熟相关的基因。此外,还评估了术前基因表达与术后形态之间的关系。还对 AVF 进行了 RNA-seq 分析,以寻找在转位时成熟和失败的 AVF 之间的转录差异。
在术前失败的静脉中,促炎基因(CSF3R、FPR1、S100A8、S100A9 和 VNN2)上调(错误发现率<0.05),其表达与平滑肌细胞共定位。S100A8 和 S100A9 的表达与术后内膜增生以及中膜纤维化和内膜增生的产物相关(r=0.32-0.38;P<0.05)。在转位时成熟或失败的 AVF 在转录上相似。
样本量小,仅分析上臂静脉和转位瘘。
术前静脉中促炎基因的表达增加似乎与 AVF 不成熟的风险增加有关。